A real-world clinical study of camrelizumab in the treatment of esophageal cancer.

Guoping Sun,Dong Qian,Dong Zhao,Hui Liang,Huaidong Cheng,Genhe Wang,Fan Wang,Hao Jiang,Tengyun Xu,Qibing Wu,ShaoJin Zhu,Dong Xu

A real-world clinical study of camrelizumab in the treatment of esophageal cancer.

2021

Guoping Sun
Dong Qian
Dong Zhao
Hui Liang
Huaidong Cheng
Genhe Wang
Fan Wang
Hao Jiang
Tengyun Xu
Qibing Wu
ShaoJin Zhu
Dong Xu

e16008Background: Camrelizumab, a fully humanized monoclonal antibody against PD-1, has been approved in the treatment of advanced esophageal squamous carcinoma in China. The purpose of this study ...

Keywords:

Medicine
Internal medicine
Oncology
clinical study
Esophageal cancer
squamous carcinoma
Monoclonal antibody

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations